Formulary Drug Reviews: Nirsevimab.
| Autor: | Levien TL; Washington State University, Spokane, WA, USA., Baker DE; Washington State University, Spokane, WA, USA. |
|---|---|
| Jazyk: | angličtina |
| Zdroj: | Hospital pharmacy [Hosp Pharm] 2024 Apr; Vol. 59 (2), pp. 138-145. Date of Electronic Publication: 2023 Nov 19. |
| DOI: | 10.1177/00185787231212620 |
| Abstrakt: | Each month, subscribers to The Formulary Monograph Service receive 5 to 6 well-documented monographs on drugs that are newly released or are in late phase 3 trials. The monographs are targeted to Pharmacy & Therapeutics Committees. Subscribers also receive monthly 1-page summary monographs on agents that are useful for agendas and pharmacy/nursing in-services. A comprehensive target drug utilization evaluation/medication use evaluation (DUE/MUE) is also provided each month. With a subscription, the monographs are available online to subscribers. Monographs can be customized to meet the needs of a facility. Through the cooperation of The Formulary, Hospital Pharmacy publishes selected reviews in this column. For more information about The Formulary Monograph Service , contact Wolters Kluwer customer service at 866-397-3433. Competing Interests: The author(s) declared no potential conflicts of interest with respect to the research, authorship, and/or publication of this article. (© The Author(s) 2023.) |
| Databáze: | MEDLINE |
| Externí odkaz: |
|